Role of the inflammasome in inflammatory responses and subsequent injury after hepatic ischemia‐reperfusion injury
Yoshiyuki Inoue, Yoshikazu Yasuda, Masafumi Takahashi – 21 May 2013
Hepatic gene therapy using lentiviral vectors: Has safety been established?
David Dismuke, R. Jude Samulski – 20 May 2013
Platelet‐derived growth factor D: A new player in the complex cross‐talk between cholangiocarcinoma cells and cancer‐associated fibroblasts
Carmen Berasain, Matias A. Ávila – 20 May 2013
NK cells of mice phagocytose hMSCs
Jin‐Zhong Dong, Li‐Ping Wang, Chun‐Wei Shi, Sai‐Nan Zhang, Ming‐Qin Lu – 20 May 2013
Vitamin D nuclear receptor deficiency promotes cholestatic liver injury by disruption of biliary epithelial cell junctions in mice
Delphine Firrincieli, Silvia Zúñiga, Colette Rey, Dominique Wendum, Elisabeth Lasnier, Dominique Rainteau, Thomas Braescu, Thomas Falguières, Mathieu Boissan, Axelle Cadoret, Chantal Housset, Nicolas Chignard – 20 May 2013 – Alterations in apical junctional complexes (AJCs) have been reported in genetic or acquired biliary diseases. The vitamin D nuclear receptor (VDR), predominantly expressed in biliary epithelial cells in the liver, has been shown to regulate AJCs.
Utility of magnetic resonance imaging versus histology for quantifying changes in liver fat in nonalcoholic fatty liver disease trials
Mazen Noureddin, Jessica Lam, Michael R. Peterson, Michael Middleton, Gavin Hamilton, Thuy‐Anh Le, Ricki Bettencourt, Chris Changchien, David A. Brenner, Claude Sirlin, Rohit Loomba – 20 May 2013 – The magnetic resonance imaging–estimated proton density fat fraction (MRI‐PDFF) is a novel imaging‐based biomarker that allows fat mapping of the entire liver, whereas the magnetic resonance spectroscopy–measured proton density fat fraction (MRS‐PDFF) provides a biochemical measure of liver fat in small regions of interest.
Reply
Tzu‐Wei Wu, Hans Hsienhong Lin, Li‐Yu Wang – 20 May 2013
Utility of magnetic resonance imaging versus histology for quantifying changes in liver fat in nonalcoholic fatty liver disease trials
Mazen Noureddin, Jessica Lam, Michael R. Peterson, Michael Middleton, Gavin Hamilton, Thuy‐Anh Le, Ricki Bettencourt, Chris Changchien, David A. Brenner, Claude Sirlin, Rohit Loomba – 20 May 2013 – The magnetic resonance imaging–estimated proton density fat fraction (MRI‐PDFF) is a novel imaging‐based biomarker that allows fat mapping of the entire liver, whereas the magnetic resonance spectroscopy–measured proton density fat fraction (MRS‐PDFF) provides a biochemical measure of liver fat in small regions of interest.
Ketamine abuse, biliary tract disease, and secondary sclerosing cholangitis
Aaron Turkish, Jean J. Luo, Jay H. Lefkowitch – 20 May 2013